Skip to main content

Halozyme Therapeutic(HALO-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Halozyme Provides 2023 Financial Guidance and Outlook

PR Newswire - Tue Jan 10, 2023

2023 Total Revenue Guidance of $815 to $845 Million Representing >20% Growth Over Expected 2022 Revenue

2023 Recurring Revenues from Royalties Projected to Grow by >20% to $445 to $455 Million

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe